P. Engel

Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition

I. Gram, F. Clavel-Chapelon, A. Fournier, 2011, British Journal of Cancer.

Serum 25(OH) Vitamin D and Risk of Breast Cancer: A Nested Case-Control Study from the French E3N Cohort

F. Clavel-Chapelon, S. Mesrine, M. Boutron‐Ruault, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Plasma phospholipid fatty acid concentrations and risk of gastric adenocarcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).

F. Clavel-Chapelon, E. Riboli, P. Vineis, 2011, The American journal of clinical nutrition.

Dietary Intake of Vitamin D and Calcium and Breast Cancer Risk in the European Prospective Investigation into Cancer and Nutrition

J. Chang-Claude, F. Clavel-Chapelon, E. Riboli, 2013, Nutrition and cancer.

Prediagnostic circulating parathyroid hormone concentration and colorectal cancer in the European Prospective Investigation into Cancer and Nutrition cohort.

K. Straif, F. Clavel-Chapelon, E. Riboli, 2011, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Vitamin D receptor and calcium sensing receptor polymorphisms and the risk of colorectal cancer in European populations.

F. Clavel-Chapelon, F. Berrino, E. Riboli, 2009, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Latitude and ultraviolet radiation dose in the birthplace in relation to menarcheal age in a large cohort of French women.

F. Clavel-Chapelon, J. Verdebout, B. Fervers, 2013, International journal of epidemiology.

ONCOGRAM: study protocol for the evaluation of therapeutic response and survival of metastatic colorectal cancer patients treated according to the guidelines of a chemosensitivity assay, the Oncogramme®

B. Chauffert, Y. Bécouarn, M. Pradel, 2021, Trials.

Variation in genes coding for AMP-activated protein kinase (AMPK) and breast cancer risk in the European Prospective Investigation on Cancer (EPIC)

I. Gram, J. Chang-Claude, F. Clavel-Chapelon, 2011, Breast Cancer Research and Treatment.

Postmenopausal Serum Sex Steroids and Risk of Hormone Receptor–Positive and -Negative Breast Cancer: a Nested Case–Control Study

R. E. James, J. Chang-Claude, F. Clavel-Chapelon, 2011, Cancer Prevention Research.

Risk of osteoporotic fractures after discontinuation of menopausal hormone therapy: results from the E3N cohort.

Françoise Clavel-Chapelon, F. Clavel-Chapelon, A. Fournier, 2011, American journal of epidemiology.

Joint Effects of Dietary Vitamin D and Sun Exposure on Breast Cancer Risk: Results from the French E3N Cohort

F. Clavel-Chapelon, S. Mesrine, M. Boutron‐Ruault, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Design of the Ocrelizumab Pregnancy Registry to Assess Maternal, Fetal and Infant Outcomes in Women With Multiple Sclerosis Who Were Exposed to Ocrelizumab During, or Within 6 Months Before, Pregnancy (P4.367)

P. Engel, D. Wormser, K. Hellwig, 2018, Neurology.

Joint Effects of Dietary Vitamin D and Sun Exposure on Breast Cancer Risk: Results from the French E3N Cohort

F. Clavel-Chapelon, S. Mesrine, M. Boutron‐Ruault, 2010, Cancer Epidemiology, Biomarkers & Prevention.

American Journal of Epidemiology Original Contribution Risk of Osteoporotic Fractures after Discontinuation of Menopausal Hormone Therapy: Results from the E3n Cohort

S. Mesrine, M. Boutron‐Ruault, P. Engel, 2022 .